# OnCo record memantine (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/memantine/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "memantine" ;
  schema:name "Memantine"@en ;
  schema:alternateName "Ebixa"@en, "Namenda" ;
  schema:description "Memantine is an Alzheimer's drug taken during whole-brain radiotherapy to protect memory. With hippocampal-sparing radiotherapy it has become the standard way to limit the thinking problems the treatment causes."@en ;
  schema:url <https://onco.cc/drugs/memantine/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Memantine> ;
  schema:citation <https://en.wikipedia.org/wiki/Memantine> ;
  onco:status "approved" ;
  onco:tag "subtype-drugs-wave" ;
  onco:modality "Oral NMDA receptor antagonist (neuroprotectant)" ;
  onco:approval "US 2003: Moderate to severe Alzheimer's disease (use as a neuroprotectant during whole-brain radiotherapy is off-label)" ;
  onco:related <https://onco.cc/terms/wbrt/> ;
  onco:cancers <https://onco.cc/cancers/secondary-brain-tumours/> .